60 results
POS AM
SYRE
Spyre Therapeutics Inc.
26 Mar 24
Prospectus update (post-effective amendment)
6:30pm
in our industry with the breadth of skills and experience required to successfully develop, facilitate regulatory approval of and commercialize product … the table. These descriptions include the primary individual experience, qualifications, qualities and skills of each of our directors.
Name
POS AM
SYRE
Spyre Therapeutics Inc.
14 Mar 24
Prospectus update (post-effective amendment)
4:12pm
of skills and experience required to successfully develop, facilitate regulatory approval of and commercialize product candidates. Competition to hire from … . These descriptions include the primary individual experience, qualifications, qualities and skills of each of our directors.
Name of Director
Age
Principal Occupation
POS AM
cefx9
5 Mar 24
Prospectus update (post-effective amendment)
5:15pm
PRER14A
r72aw7
6 Oct 23
Preliminary revised proxy
9:40pm
8-K
EX-99.1
8jq4b3e
5 Sep 23
Aeglea BioTherapeutics Expands Executive Leadership Team with Appointment of Industry Veterans Scott Burrows and Heidy Abreu King-Jones
7:06am